These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 1383099)

  • 21. Results of the Tokyo trial of prevention of post-ERCP pancreatitis with risperidone-2: a multicenter, randomized, placebo-controlled, double-blind clinical trial.
    Uchino R; Isayama H; Tsujino T; Sasahira N; Ito Y; Matsubara S; Takahara N; Arizumi T; Toda N; Mohri D; Togawa O; Yagioka H; Yanagihara Y; Nakajima K; Akiyama D; Hamada T; Miyabayashi K; Mizuno S; Kawakubo K; Kogure H; Sasaki T; Yamamoto N; Nakai Y; Hirano K; Tada M; Koike K
    Gastrointest Endosc; 2013 Dec; 78(6):842-850. PubMed ID: 23910063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of post-ERCP acute pancreatitis with octreotide].
    Baldazzi G; Conti C; Spotti EG; Arisi GP; Scevola M; Gobetti F; Agliardi CM; Galasso P; Bonomi E; Bianchi F
    G Chir; 1994; 15(8-9):359-62. PubMed ID: 7803209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis.
    Lv ZH; Kou DQ; Guo SB
    BMC Gastroenterol; 2020 Apr; 20(1):118. PubMed ID: 32306904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-6, IL-10 and TNFα do not improve early detection of post-endoscopic retrograde cholangiopancreatography acute pancreatitis: a prospective cohort study.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Mora J; Vidal S; Díez X; Torras X; Sainz S; Villanueva C; Farré A; Guarner-Argente C; Guarner C
    Sci Rep; 2016 Sep; 6():33492. PubMed ID: 27642079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aggressive hydration with lactated Ringer's solution reduces pancreatitis after endoscopic retrograde cholangiopancreatography.
    Buxbaum J; Yan A; Yeh K; Lane C; Nguyen N; Laine L
    Clin Gastroenterol Hepatol; 2014 Feb; 12(2):303-7.e1. PubMed ID: 23920031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized study of the effect of pentoxifylline or octreotide on serum levels of TNF-alpha and IL-6 after endoscopic retrograde cholangiopancreatography.
    Kapetanos D; Christodoulou D; Chatzizisi O; Sigounas D; Vasiliou K; Stavropoulou E; Katodritou E; Kokozidis G; Kiriazis G; Kitis G; Tsianos E
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):529-33. PubMed ID: 19373973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
    Milewski J; Rydzewska G; Degowska M; Kierzkiewicz M; Rydzewski A
    World J Gastroenterol; 2006 Jun; 12(23):3751-5. PubMed ID: 16773694
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
    Hardt PD; Kress O; Fadgyas T; Doppl W; Schnell-Kretschmer H; Wüsten O; Klör HU
    Eur J Med Res; 2000 Apr; 5(4):165-70. PubMed ID: 10799351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
    Kapetanos D; Kokozidis G; Kinigopoulou P; Xiarchos P; Antonopoulos Z; Progia E; Kitis G
    Hepatogastroenterology; 2007 Mar; 54(74):556-60. PubMed ID: 17523321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting and preventing post-ERCP pancreatitis.
    Baillie J
    Curr Gastroenterol Rep; 2002 Apr; 4(2):112-9. PubMed ID: 11900675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
    Devière J; Le Moine O; Van Laethem JL; Eisendrath P; Ghilain A; Severs N; Cohard M
    Gastroenterology; 2001 Feb; 120(2):498-505. PubMed ID: 11159890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisecretory vs. antiproteasic drugs in the prevention of post-ERCP pancreatitis: the evidence-based medicine derived from a meta-analysis study.
    Andriulli A; Caruso N; Quitadamo M; Forlano R; Leandro G; Spirito F; De Maio G
    JOP; 2003 Jan; 4(1):41-8. PubMed ID: 12555015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting post-endoscopic retrograde cholangiopancreatography pancreatitis using the 4-h serum lipase level.
    Papachristos A; Howard T; Thomson BN; Thomas PR
    ANZ J Surg; 2018 Jan; 88(1-2):82-86. PubMed ID: 27457275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin for prevention of post-ERCP pancreatitis: a randomized, double-blind trial.
    Concepción-Martín M; Gómez-Oliva C; Juanes A; Díez X; Prieto-Alhambra D; Torras X; Sainz S; Villanueva C; Farre A; Guarner-Argente C; Guarner C
    Endoscopy; 2014 Oct; 46(10):851-6. PubMed ID: 24977398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
    Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
    Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transdermal glyceryl trinitrate for prevention of post-ERCP pancreatitis: A randomized double-blind trial.
    Moretó M; Zaballa M; Casado I; Merino O; Rueda M; Ramírez K; Urcelay R; Baranda A
    Gastrointest Endosc; 2003 Jan; 57(1):1-7. PubMed ID: 12518122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prophylactic effect of somatostatin on post-therapeutic endoscopic retrograde cholangiopancreatography pancreatitis: a randomized, multicenter controlled trial.
    Lee KT; Lee DH; Yoo BM
    Pancreas; 2008 Nov; 37(4):445-8. PubMed ID: 18953260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.